The largest database of trusted experimental protocols

Atbexpression automatic bacterial identification instrument

Manufactured by bioMérieux
Sourced in France

The ATBExpression is an automatic bacterial identification instrument developed by bioMérieux. It is designed to perform rapid and accurate identification of bacterial strains. The instrument utilizes advanced technology to analyze and interpret the growth patterns of bacterial cultures, providing reliable identification results to assist in clinical diagnosis and treatment decision-making.

Automatically generated - may contain errors

2 protocols using atbexpression automatic bacterial identification instrument

1

Comprehensive Respiratory Pathogen Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total nucleic acids were extracted from respiratory and blood samples using a NucliSens easyMAG apparatus (bioMerieux, Marcy l′Etoile, France). The presence of HRVs and other common respiratory pathogens were screened using the fast-track diagnostic respiratory pathogens 21 plus kit (2013 version, Fast-track diagnostics, Junglinster, Luxembourg), which included HRVs, IFVA and B, human coronaviruses (HCoV, OC43, 229E, NL63, and HKU1), parainfluenza viruses, human metapneumovirus (A and B), EV, RSV (A and B), adenovirus, bocavirus, parechovirus, Mycoplasma pneumoniae, Chlamydia pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae B, and Staphylococcus aureus. Bacterial culture was performed on lower respiratory samples and acute sera using an ATBExpression automatic bacterial identification instrument (bioMerieux, Marcy l′Etoile, France).
+ Open protocol
+ Expand
2

BALF Analysis of Stable COPD Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty-five COPD cases and nine non-COPD controls (not paired) were enrolled in this study. All COPD subjects were in a stable state (at least 8 weeks without exacerbation or use of antibiotics). The exclusion conditions included known cardiovascular diseases, renal or liver insufficiency, bronchiectasis, active pulmonary tuberculosis, bronchial asthma, pulmonary fibrosis, and lung cancer. Non-COPD controls had had no respiratory tract infection symptoms in the three months before submitting to bronchoscope examination. Clinical information was obtained for each enrolled patient (Table S1 in the supplemental material).
BALF samples were collected from each subject using a bronchoscope as part of normal clinical management. Two aliquots of 50 ml sterile isotonic saline solution were instilled, with 50% of the volume recovered on average. The BALF samples were immediately placed on ice and processed within 30 min. Bacterial culturing was performed on the BALF samples using an ATB Expression automatic bacterial identification instrument (bioMérieux, Marcy l’Etoile, France). The remnant samples were aliquoted and stored at −80°C before processing. Two negative controls (saline solution passed through a new bronchoscope and a reused sterilized bronchoscope) were collected and processed following the same library preparation protocol.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!